REVIEW ARTICLE ON ANTIFUNGAL AGENTS USED IN MUCORMYCOSIS

Dr. Shital J. Patil*, Bhumika S. Gaikwad, Yash K. Gangurde, Shubhangi V. Pawar, Prachiti S. Jagtap, Komal R. Ghadge

Mucormycosis is a severe fungal infection caused by Mucorales fungi, which are found in soil and decaying organic matter. Immunocompromised people, such as those with severe COVID-19 disease, organ transplant recipients, cancer, or uncontrolled diabetes, are the main victims. The most prevalent kinds are disseminated, pulmonary, cutaneous, gastrointestinal, and rhino-orbital-cerebral. Fever, headaches, face discomfort, eyesight issues, and skin lesions are some of the symptoms. Microscopic analysis and tissue biopsy are frequently needed for diagnosis. Antifungal drugs and surgical debridement are the usual forms of therapy; nevertheless, because of the high death rates, particularly in instances that are widespread, early detection and intervention are essential.